Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Treatment received by patients with immune-mediated inflammatory disorders (IMID).
| Treatment | PS | GD | SpA | RA | Total |
|---|---|---|---|---|---|
| Secukinumab (anti-IL17) | 4 | 3 | 7 | ||
| Ixekizumab (anti-IL17) | 2 | 2 | |||
| Adalimumab (anti-TNFα) | 4 | 4 | 8 | ||
| Certolizumab (anti-TNFα) | 7 | 7 | |||
| Ustekinumab (anti-IL12/23) | 2 | 2 | |||
| Rituximab (anti-CD20) | 8 | 8 | |||
| Tocilizumab (anti-IL6) | 8 | 2 | 10 | ||
| Baricitinib (JAKs inhibitors) | 4 | 4 |
PS: psoriasis; GD: Graves´ disease; SpA: spondyloarthritis; RA: rheumatoid arthritis.
